Qualigen Therapeutics Inc. (AIXC)
NASDAQ · Healthcare
Qualigen Therapeutics Inc. annual/quarterly shareholder equity history from 2020 to 2022. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Qualigen Therapeutics Inc. shareholder equity for the quarter ending December 31, 2022 were 7.2M, a 56.32% decrease year-over-year.
- Qualigen Therapeutics Inc. shareholder equity for 2022 were 7.2M, a 56.32% decrease from 2021.
- Qualigen Therapeutics Inc. shareholder equity for 2021 were 16.6M, a 9.46% decrease from 2020.
- Qualigen Therapeutics Inc. shareholder equity for 2020 were 18.3M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Qualigen Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2022 | $7 |
| 2021 | $17 |
| 2020 | $18 |
| Qualigen Therapeutics Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2022-12-31 | $7 |
| 2021-12-31 | $17 |
| 2020-12-31 | $18 |
| 2020-03-31 | $-2 |
Qualigen Therapeutics Inc. Shareholder Equity — FAQ
Qualigen Therapeutics Inc. (AIXC) shareholder equity over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AIXC's shareholder equity history?
The chart and table above show Qualigen Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.